Physician profile
Tracey Floyd
NPI 1528318151
$721.29
in general payments reported to CMS, 2019-2025
19 companies · $16.76 in 2025
The $16.76 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $261 · 2022: $147 · 2023: $220 · 2024: $76.10 · 2025: $16.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $172.86 | 2021-2023 | |
| Exact Sciences Corporation | $93.83 | 2023-2024 | Cologuard Collection Kit |
| Harmony Biosciences LLC | $63.54 | 2022 | |
| Lilly USA, LLC | $42.85 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.18 | 2023 | Xifaxan |
| Impel Pharmaceuticals INC. | $35.06 | 2023 | Trudhesa |
| Otsuka America Pharmaceutical, INC. | $33.11 | 2021-2023 | Rexulti |
| Corcept Therapeutics | $31.72 | 2022-2023 | Korlym |
| Phadia US INC. | $28.00 | 2023-2024 | Immunocap |
| Amgen INC. | $26.67 | 2021 | |
| Bausch Health US, LLC | $24.15 | 2022 | |
| Astellas Pharma US INC | $20.00 | 2023 | Veozah |
| Kowa Pharmaceuticals America, INC. | $17.60 | 2021 | |
| Amarin Pharma, INC. | $17.32 | 2021 | |
| Abbott Laboratories | $16.76 | 2025 | Freestyle Libre 3 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $16.28 | 2022 | |
| Lundbeck LLC | $14.17 | 2023 | Rexulti |
| Astrazeneca Pharmaceuticals Lp | $13.28 | 2023 | Breztri |
| Merck Sharp & Dohme LLC | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Floyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.